Author Archives for Stemedica International

Clinical Trials for Alzheimer’s Disease (CTAD) Selects Stemedica International to Present at Annual International Conference

November 21, 2016 9:51 am Published by Comments Off on Clinical Trials for Alzheimer’s Disease (CTAD) Selects Stemedica International to Present at Annual International Conference

viagra liquid uk does cymbalta increase dopemine buy essay online com rhetorical essay topics dapoxetine price in india resume writing service bbb https://geneseelandlordassoc.org/category/do-my-homework-now/44/ source see url cialis 20 mg cheap can you break lisinopril in half levitra online buy follow link popular essay writers best essays online essay on quiz competition in school research paper john the baptist buy essays online from scratch how to write a dvd on macbook pro funny viagra jokes computer essay short go apush essays sample generic female viagra sildenafil citrate https://grad.cochise.edu/college/cv-writing-service-uk/20/ birth order essay age discrimination case study samsung text to speech https://jesuswired.com/writing/buying-college-report-papers/12/ website that will write an essay for you follow url go site San Diego, California and Lausanne, Switzerland — November 21, 2016 Stemedica International, SA, a leader in the development of innovative stem...
Read Entire Article


University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

November 1, 2016 5:55 am Published by Comments Off on University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

IRVINE, CA — November 1, 2016 — Stemedica International, SA, a Stemedica Cell Technologies Inc. subsidiary that uses its proprietary...
Read Entire Article


University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

October 26, 2016 9:53 am Published by Comments Off on University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

Lausanne, Switzerland — October 26, 2016 Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s...
Read Entire Article


Stemedica International Receives Approval from Emory University to Initiate Alzheimer’s Disease Study with Adult Allogeneic Stem Cells

February 24, 2016 5:54 am Published by Comments Off on Stemedica International Receives Approval from Emory University to Initiate Alzheimer’s Disease Study with Adult Allogeneic Stem Cells

Lausanne, Switzerland — February 24, 2016 — Stemedica International, SA, a leader in the development of innovative stem cell-based treatments...
Read Entire Article